Literature DB >> 15607539

Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.

S Hussein-Fikret1, P J Fuller.   

Abstract

Granulosa cell tumours of the ovary (GCT) exhibit high expression of estrogen receptor beta (ERbeta). A role for estrogen receptors in these tumours may depend on altered co-activator expression. This study examines the expression of the co-activators SRC-1a/e, SRC-2, SRC-3, SRA, and the corepressors NCoR and SMRT in GCT, epithelial ovarian tumours and normal ovary. No significant difference in the expression of SRC-1, SRC-2, SRC-3 or NCoR and SMRT was found. In particular, there was no correlation of co-activator expression with ERbeta expression. There was a significant upregulation in the expression of the novel RNA co-activator SRA in the serous tumours compared with the other tumour types and normal ovary. The findings suggest that ERbeta may require co-activators, other than members of the SRC family for the modulation of transcription in GCT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607539     DOI: 10.1016/j.mce.2004.08.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

Review 1.  Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.

Authors:  Robert G Maki
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

Review 2.  Steroid receptor coactivators as therapeutic targets in the female reproductive system.

Authors:  Maria M Szwarc; John P Lydon; Bert W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  2015-07-04       Impact factor: 4.292

3.  Truncated SRA RNA derivatives inhibit estrogen receptor-α-mediated transcription.

Authors:  Euihan Jung; Seonghui Jang; Jungmin Lee; Youngmi Kim; Heegwon Shin; Hee-Sung Park; Younghoon Lee
Journal:  Mol Biol Rep       Date:  2016-07-12       Impact factor: 2.316

Review 4.  Long non-coding RNA regulation of reproduction and development.

Authors:  David H Taylor; Erin Tsi-Jia Chu; Roman Spektor; Paul D Soloway
Journal:  Mol Reprod Dev       Date:  2015-10-30       Impact factor: 2.609

5.  Nuclear receptor profiling of ovarian granulosa cell tumors.

Authors:  Maria Alexiadis; Natalie Eriksson; Stacey Jamieson; Melissa Davis; Ann E Drummond; Simon Chu; Colin D Clyne; George E Muscat; Peter J Fuller
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

6.  Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin.

Authors:  D I Wu; Tianzhen Wang; Chengcheng Ren; Lei Liu; Dan Kong; Xiaoming Jin; Xiaobo Li; Guangmei Zhang
Journal:  Oncol Lett       Date:  2015-12-01       Impact factor: 2.967

Review 7.  Non-coding RNA in Ovarian Development and Disease.

Authors:  J Browning Fitzgerald; Jitu George; Lane K Christenson
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 8.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

9.  Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients.

Authors:  Yi Yan; George P Skliris; Carla Penner; Shilpa Chooniedass-Kothari; Charlton Cooper; Zoann Nugent; Anne Blanchard; Peter H Watson; Yvonne Myal; Leigh C Murphy; Etienne Leygue
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

Review 10.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.

Authors:  Katherine M Scarpin; J Dinny Graham; Patricia A Mote; Christine L Clarke
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.